<scp>Patient‐reported</scp> outcomes of a phase <scp>II</scp> neoadjuvant apalutamide ( <scp>ARN</scp> ‐509) and radical prostatectomy in treatment of intermediate‐ to <scp>high‐risk</scp> prostate cancer ( <scp>NEAR</scp> ) trial-Reference-Cited by-同舟云学术

Patient‐reported outcomes of a phase II neoadjuvant apalutamide ( ARN ‐509) and radical prostatectomy in treatment of intermediate‐ to high‐risk prostate cancer ( NEAR ) trial

Published:2022-08-24 Issue:11 Volume:29 Page:1322-1330
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Yang Xinyan¹^ORCID,Allen John Carson²,Aslim Edwin Jonathan¹³,Tay Kae Jack¹³^ORCID,Yuen Shyi Peng John¹³,Kanesvaran Ravindran³⁴,Chua Melvin Lee Kiang³⁵,Chong Tsung Wen¹³,Ho Sun Sien Henry¹³,Lee Lui Shiong³⁶^ORCID

Affiliation:

1. Department of Urology Singapore General Hospital Singapore

2. Centre for Quantitative Medicine/Office of Research Duke‐NUS Medical School Singapore

3. Duke‐NUS Medical School Singapore

4. Division of Medical Oncology National Cancer Centre Singapore

5. Divisions of Radiation Oncology and Medical Sciences National Cancer Centre Singapore

6. Department of Urology Sengkang General Hospital Singapore

Publisher

Wiley

Subject

Urology

Link